Migraine Treatment Strategies for Managed Care Pharmacists

Stratified Care Using the MIDAS Questionnaire

Walter F. Stewart, Richard B. Lipton

Research output: Contribution to journalArticle

Abstract

A majority of migraine headache sufferers experience moderate to severe disability from attacks, yet most are not effectively treated or satisfied with care. The Migraine Disability Assessment Scale (MIDAS) was developed to improve the detection of disabling migraine and to address some of the barriers migraine sufferers face in obtaining satisfactory care. The Disability in Strategies of Care (DISC) tested the hypothesis that using information about headache-related disability to select initial therapy would improve patient outcomes. The study compared stratified care, step care within attacks, and step care across attacks among 835 patients with MIDAS grades of II, III, or IV. Headache response at 2 hours was significantly greater for stratified care patients (52.7%), whose treatment was based on migraine severity, than in the step care across attacks (40.6%; p < 0.001) or the step care within attacks (36.4%; p < 0.001) groups. In our study, stratified care provided significantly better clinical outcomes than step care. Using the MIDAS questionnaire and the results of the DISC study, the pharmacist can play an important role in improving the care of migraine sufferers.

Original languageEnglish (US)
Pages (from-to)97-107
Number of pages11
JournalJournal of Managed Pharmaceutical Care
Volume1
Issue number2
DOIs
StatePublished - 2001

Fingerprint

Managed Care Programs
Migraine Disorders
Pharmacists
Therapeutics
Headache
Surveys and Questionnaires
Patient Care

Keywords

  • Clinical trial
  • Disability
  • Headache
  • Health services
  • Migraine
  • Outcomes
  • Pain
  • Treatment

ASJC Scopus subject areas

  • Pharmacology
  • Leadership and Management

Cite this

Migraine Treatment Strategies for Managed Care Pharmacists : Stratified Care Using the MIDAS Questionnaire. / Stewart, Walter F.; Lipton, Richard B.

In: Journal of Managed Pharmaceutical Care, Vol. 1, No. 2, 2001, p. 97-107.

Research output: Contribution to journalArticle

@article{1e8c2fc6c5ca491ba5bb89131ed1fc9d,
title = "Migraine Treatment Strategies for Managed Care Pharmacists: Stratified Care Using the MIDAS Questionnaire",
abstract = "A majority of migraine headache sufferers experience moderate to severe disability from attacks, yet most are not effectively treated or satisfied with care. The Migraine Disability Assessment Scale (MIDAS) was developed to improve the detection of disabling migraine and to address some of the barriers migraine sufferers face in obtaining satisfactory care. The Disability in Strategies of Care (DISC) tested the hypothesis that using information about headache-related disability to select initial therapy would improve patient outcomes. The study compared stratified care, step care within attacks, and step care across attacks among 835 patients with MIDAS grades of II, III, or IV. Headache response at 2 hours was significantly greater for stratified care patients (52.7{\%}), whose treatment was based on migraine severity, than in the step care across attacks (40.6{\%}; p < 0.001) or the step care within attacks (36.4{\%}; p < 0.001) groups. In our study, stratified care provided significantly better clinical outcomes than step care. Using the MIDAS questionnaire and the results of the DISC study, the pharmacist can play an important role in improving the care of migraine sufferers.",
keywords = "Clinical trial, Disability, Headache, Health services, Migraine, Outcomes, Pain, Treatment",
author = "Stewart, {Walter F.} and Lipton, {Richard B.}",
year = "2001",
doi = "10.1300/J234v01n02_11",
language = "English (US)",
volume = "1",
pages = "97--107",
journal = "Journal of Managed Pharmaceutical Care",
issn = "1534-9713",
publisher = "Pharmaceutical Products Press",
number = "2",

}

TY - JOUR

T1 - Migraine Treatment Strategies for Managed Care Pharmacists

T2 - Stratified Care Using the MIDAS Questionnaire

AU - Stewart, Walter F.

AU - Lipton, Richard B.

PY - 2001

Y1 - 2001

N2 - A majority of migraine headache sufferers experience moderate to severe disability from attacks, yet most are not effectively treated or satisfied with care. The Migraine Disability Assessment Scale (MIDAS) was developed to improve the detection of disabling migraine and to address some of the barriers migraine sufferers face in obtaining satisfactory care. The Disability in Strategies of Care (DISC) tested the hypothesis that using information about headache-related disability to select initial therapy would improve patient outcomes. The study compared stratified care, step care within attacks, and step care across attacks among 835 patients with MIDAS grades of II, III, or IV. Headache response at 2 hours was significantly greater for stratified care patients (52.7%), whose treatment was based on migraine severity, than in the step care across attacks (40.6%; p < 0.001) or the step care within attacks (36.4%; p < 0.001) groups. In our study, stratified care provided significantly better clinical outcomes than step care. Using the MIDAS questionnaire and the results of the DISC study, the pharmacist can play an important role in improving the care of migraine sufferers.

AB - A majority of migraine headache sufferers experience moderate to severe disability from attacks, yet most are not effectively treated or satisfied with care. The Migraine Disability Assessment Scale (MIDAS) was developed to improve the detection of disabling migraine and to address some of the barriers migraine sufferers face in obtaining satisfactory care. The Disability in Strategies of Care (DISC) tested the hypothesis that using information about headache-related disability to select initial therapy would improve patient outcomes. The study compared stratified care, step care within attacks, and step care across attacks among 835 patients with MIDAS grades of II, III, or IV. Headache response at 2 hours was significantly greater for stratified care patients (52.7%), whose treatment was based on migraine severity, than in the step care across attacks (40.6%; p < 0.001) or the step care within attacks (36.4%; p < 0.001) groups. In our study, stratified care provided significantly better clinical outcomes than step care. Using the MIDAS questionnaire and the results of the DISC study, the pharmacist can play an important role in improving the care of migraine sufferers.

KW - Clinical trial

KW - Disability

KW - Headache

KW - Health services

KW - Migraine

KW - Outcomes

KW - Pain

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=0346123139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346123139&partnerID=8YFLogxK

U2 - 10.1300/J234v01n02_11

DO - 10.1300/J234v01n02_11

M3 - Article

VL - 1

SP - 97

EP - 107

JO - Journal of Managed Pharmaceutical Care

JF - Journal of Managed Pharmaceutical Care

SN - 1534-9713

IS - 2

ER -